Carmed Pharmaceuticals Advances U.S. Entry with Science-Driven Botanical Formulations
BOCA RATON, FL – 21/03/2026 – ( SeaPRwire ) – Carmed Pharmaceuticals, a research-oriented company focused on standardized botanical formulations, has initiated its expansion into the United States, marking a new phase in its international growth strategy. The move reflects the company’s continued emphasis on integrating scientifically validated approaches into the development of plant-based wellness solutions. Founded in 2019 by Mustafa Can, Carmed Pharmaceuticals emerged from years of independent scientific inquiry into botanical bioactives, particularly carvacrol and its role in mechanism-based formulation design. The company has since evolved into a structured organization dedicated to bridging traditional botanical knowledge with modern pharmaceutical methodologies. Carmed’s development philosophy centers on creating formulations that are standardized, reproducible, and supported by analytical validation. Its product design framework focuses on supporting immune resilience, cell...